{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/javascript": [
       "(function(on) {\n",
       "const e=$( \"<a>Setup failed</a>\" );\n",
       "const ns=\"js_jupyter_suppress_warnings\";\n",
       "var cssrules=$(\"#\"+ns);\n",
       "if(!cssrules.length) cssrules = $(\"<style id='\"+ns+\"' type='text/css'>div.output_stderr { } </style>\").appendTo(\"head\");\n",
       "e.click(function() {\n",
       "    var s='Showing';  \n",
       "    cssrules.empty()\n",
       "    if(on) {\n",
       "        s='';\n",
       "        cssrules.append(\"div.output_stderr, div[data-mime-type*='.stderr'] { display:none; }\");\n",
       "    }\n",
       "    e.text(s+'');\n",
       "    on=!on;\n",
       "}).click();\n",
       "$(element).append(e);\n",
       "})(true);\n"
      ],
      "text/plain": [
       "<IPython.core.display.Javascript object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "%%javascript\n",
    "(function(on) {\n",
    "const e=$( \"<a>Setup failed</a>\" );\n",
    "const ns=\"js_jupyter_suppress_warnings\";\n",
    "var cssrules=$(\"#\"+ns);\n",
    "if(!cssrules.length) cssrules = $(\"<style id='\"+ns+\"' type='text/css'>div.output_stderr { } </style>\").appendTo(\"head\");\n",
    "e.click(function() {\n",
    "    var s='Showing';  \n",
    "    cssrules.empty()\n",
    "    if(on) {\n",
    "        s='';\n",
    "        cssrules.append(\"div.output_stderr, div[data-mime-type*='.stderr'] { display:none; }\");\n",
    "    }\n",
    "    e.text(s+'');\n",
    "    on=!on;\n",
    "}).click();\n",
    "$(element).append(e);\n",
    "})(true);"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# COVID-19 Vaccine and Treatment Development Tracker\n",
    "\n",
    "Welcome to **covid-vaccine-tracker.com**. This website presents a summary of the data published by the **WHO** regarding the develipment of COVID-19 vaccines (https://www.who.int/blueprint/priority-diseases/key-action/novel-coronavirus-landscape-ncov.pdf?ua=1). Data for treatments for COVID-19 under development is derived from the **Milken Institute** vaccine and treatment spreadsheet (https://milkeninstitute.org/sites/default/files/2020-03/Covid19-Tracker-3-36-20-FINAL.pdf). No modifications have been made to the data. This has been done as an attempt to make this information more easily accessible to the public. The website is updated on a daily basis."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## COVID-19 Vaccines in Development"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### COVID-19 Vaccine Platforms in Development"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {
    "hide_input": true
   },
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Got stderr: Mar 27, 2020 11:51:25 PM org.apache.pdfbox.pdmodel.font.PDCIDFontType2 <init>\n",
      "INFO: OpenType Layout tables used in font BCDGEE+Calibri-Light are not implemented in PDFBox and will be ignored\n",
      "Mar 27, 2020 11:51:25 PM org.apache.pdfbox.pdmodel.font.PDCIDFontType2 <init>\n",
      "INFO: OpenType Layout tables used in font BCDIEE+Calibri are not implemented in PDFBox and will be ignored\n",
      "\n"
     ]
    }
   ],
   "source": [
    "\n",
    "\n",
    "import pandas as pd\n",
    "\n",
    "import tabula\n",
    "\n",
    "import requests\n",
    "\n",
    "from ggplot import *\n",
    "\n",
    "import seaborn as sns\n",
    "\n",
    "import matplotlib.pyplot as plt\n",
    "\n",
    "import numpy as np\n",
    "\n",
    "import matplotlib\n",
    "\n",
    "# Change figure sizes\n",
    "temp = plt.rcParams['figure.dpi'] = 100\n",
    "\n",
    "font = {'family' : 'normal',\n",
    "        'weight' : 'bold',\n",
    "        'size'   : 12}\n",
    "\n",
    "matplotlib.rc('font', **font)\n",
    "\n",
    "\n",
    "#url = 'https://milkeninstitute.org/sites/default/files/2020-03/Covid19-Tracker-3-36-20-FINAL.pdf'\n",
    "\n",
    "url = 'https://www.who.int/blueprint/priority-diseases/key-action/novel-coronavirus-landscape-ncov.pdf?ua=1'\n",
    "\n",
    "myfile = requests.get(url)\n",
    "open('COVID19-data.pdf', 'wb').write(myfile.content)\n",
    "\n",
    "#declare the path of your file\n",
    "file_path = \"COVID19-data.pdf\"\n",
    "#Convert your file\n",
    "df = tabula.read_pdf(file_path, pages='all', lattice=True,multiple_tables=False)\n",
    "#df = df[10]\n",
    "#df = df.drop(index=0)\n",
    "df = df[0]\n",
    "df = df.dropna(axis=0,thresh=5)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "#%% Clean the data\n",
    "\n",
    "\n",
    "df.columns = ['platform', 'type_product', 'developer', 'covid', 'stage',\n",
    "              'other']\n",
    "\n",
    "a = df['platform'].values\n",
    "aa = df['stage'].values\n",
    "b = []\n",
    "\n",
    "for i in range(len(a)):\n",
    "    #aa[i] = aa[i].replace('\\r',' ')\n",
    "    b.append(a[i].replace('\\r',' '))\n",
    "    if b[i] == 'Platform':\n",
    "        b[i] = np.nan\n",
    "\n",
    "df['platform'] = b\n",
    "\n",
    "# Evaluate the different trial types\n",
    "stages = ['Pre-Clinical', 'Phase 1', 'Phase 2', 'Phase 3']\n",
    "\n",
    "c = df['stage'].values\n",
    "stage_list = []\n",
    "\n",
    "for i in range(len(c)):\n",
    "    stage = c[i]\n",
    "    for j in range(len(stages)):\n",
    "        if stages[j] in stage:\n",
    "            stage_list.append(stages[j])\n",
    "    if len(stage_list)<i+1:\n",
    "            stage_list.append(np.nan)\n",
    "    \n",
    "\n",
    "df['stage'] = stage_list\n",
    "\n",
    "\n",
    "# Change the typer of product\n",
    "d = df['type_product'].values\n",
    "b = []\n",
    "\n",
    "for i in range(len(d)):\n",
    "    b.append(d[i].replace('\\r',' '))\n",
    "    if b[i] == 'Type of candidate vaccine':\n",
    "        b[i] = np.nan\n",
    "\n",
    "df['type_product'] = b\n",
    "\n",
    "# Change the developer names\n",
    "d = df['developer'].values\n",
    "b = []\n",
    "\n",
    "for i in range(len(d)):\n",
    "    b.append(d[i].replace('\\r',' '))\n",
    "    if b[i] == 'Developer':\n",
    "        b[i] = np.nan\n",
    "\n",
    "df['developer'] = b\n",
    "\n",
    "# Change the other names\n",
    "d = df['other'].values\n",
    "b = []\n",
    "\n",
    "for i in range(len(d)):\n",
    "    if str(d[i]) == 'nan':\n",
    "        b.append(np.nan)\n",
    "    else:\n",
    "        b.append(d[i].replace('\\r',' '))\n",
    "    if b[i] == 'Same platform for non-Coronavirus candidates':\n",
    "        b[i] = np.nan\n",
    "\n",
    "df['other'] = b"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "findfont: Font family ['normal'] not found. Falling back to DejaVu Sans.\n",
      "findfont: Font family ['normal'] not found. Falling back to DejaVu Sans.\n"
     ]
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 500x500 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "\n",
    "#%% Plot\n",
    "#fig=plt.figure(figsize=(25, 10), dpi= 80, facecolor='w', edgecolor='k')\n",
    "chart = sns.catplot(x=\"platform\", kind=\"count\", palette=\"ch:.25\", data=df);\n",
    "t = plt.xlabel('Vaccine Platform')\n",
    "t = plt.ylabel('Count')\n",
    "t = chart.set_xticklabels(rotation=90)\n",
    "\n",
    "\n",
    "#chart2 = sns.catplot(x=\"stage\", kind=\"count\", palette=\"ch:.25\", data=df);\n",
    "#t = plt.xlabel('FDA Phase')\n",
    "#t = chart2.set_xticklabels(rotation=75)\n",
    "\n",
    "#%%\n",
    "#plt.figure()\n",
    "#plat_count = df['platform'].value_counts()\n",
    "#chart3 = sns.barplot(plat_count.index, plat_count.values, alpha=0.8,palette=\"ch:.25\")\n",
    "#plt.setp(chart3.get_xticklabels(), rotation=90)\n",
    "#plt.xlabel('Vaccine Platform')\n",
    "#plt.ylabel('Count')\n",
    "\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Vaccine Clincal Trial Phase"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 500x500 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "chart2 = sns.catplot(x=\"stage\", kind=\"count\", palette=\"ch:.25\", data=df);\n",
    "t = plt.xlabel('Trial Phase')\n",
    "t = plt.ylabel('Count')\n",
    "t = chart2.set_xticklabels(rotation=0)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Vaccine Data"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "I have filtered the WHO data and made it more accessible. If you would like a spreadsheet version of this data, please email me at: *covid.vaccine.tracker@gmail.com*"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [],
   "source": [
    "df = df.drop(columns='covid')\n",
    "df.columns = ['Vaccine Platform', 'Vaccine Specifics', 'Company \\n Developer', 'Trial Stage', 'Other Uses']\n",
    "df = df.dropna(axis=0,thresh=4)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/javascript": [
       "require.config({\n",
       "    paths: {\n",
       "        datatables: 'https://cdn.datatables.net/1.10.19/js/jquery.dataTables.min',\n",
       "    }\n",
       "});\n",
       "\n",
       "$('head').append('<link rel=\"stylesheet\" type=\"text/css\" \\\n",
       "                href = \"https://cdn.datatables.net/1.10.19/css/jquery.dataTables.min.css\" > ');\n",
       "\n",
       "$('head').append('<style> table td { text-overflow: ellipsis; overflow: hidden; } </style>');\n",
       "\n",
       "$('head').append(`<script>\n",
       "function eval_functions(map_or_text) {\n",
       "    if (typeof map_or_text === \"string\") {\n",
       "        if (map_or_text.startsWith(\"function\")) {\n",
       "            try {\n",
       "                // Note: parenthesis are required around the whole expression for eval to return a value!\n",
       "                // See https://stackoverflow.com/a/7399078/911298.\n",
       "                //\n",
       "                // eval(\"local_fun = \" + map_or_text) would fail because local_fun is not declared\n",
       "                // (using var, let or const would work, but it would only be declared in the local scope\n",
       "                // and therefore the value could not be retrieved).\n",
       "                const func = eval(\"(\" + map_or_text + \")\");\n",
       "                if (typeof func !== \"function\") {\n",
       "                    // Note: backquotes are super convenient!\n",
       "                    // https://developer.mozilla.org/en-US/docs/Web/JavaScript/Reference/Template_literals\n",
       "                    console.error(\"Evaluated expression \" + map_or_text + \" is not a function (type is \" + typeof func + \")\");\n",
       "                    return map_or_text;\n",
       "                }\n",
       "                // Return the function\n",
       "                return func;\n",
       "            } catch (e) {\n",
       "                // Make sure to print the error with a second argument to console.error().\n",
       "                console.error(\"itables was not able to parse \" + map_or_text, e);\n",
       "            }\n",
       "        }\n",
       "    } else if (typeof map_or_text === \"object\") {\n",
       "        if (map_or_text instanceof Array) {\n",
       "            // Note: \"var\" is now superseded by \"let\" and \"const\".\n",
       "            // https://medium.com/javascript-scene/javascript-es6-var-let-or-const-ba58b8dcde75\n",
       "            const result = [];\n",
       "            // Note: \"for of\" is the best way to iterate through an iterable.\n",
       "            // https://developer.mozilla.org/en-US/docs/Web/JavaScript/Reference/Statements/for...of\n",
       "            for (const item of map_or_text) {\n",
       "                result.push(eval_functions(item));\n",
       "            }\n",
       "            return result;\n",
       "\n",
       "            // Alternatively, more functional approach in one line:\n",
       "            // return map_or_text.map(eval_functions);\n",
       "        } else {\n",
       "            const result = {};\n",
       "            // Object.keys() is safer than \"for in\" because otherwise you might have keys\n",
       "            // that aren't defined in the object itself.\n",
       "            //\n",
       "            // See https://stackoverflow.com/a/684692/911298.\n",
       "            for (const item of Object.keys(map_or_text)) {\n",
       "                result[item] = eval_functions(map_or_text[item]);\n",
       "            }\n",
       "            return result;\n",
       "        }\n",
       "    }\n",
       "\n",
       "    return map_or_text;\n",
       "}\n",
       "</` + 'script>');"
      ],
      "text/plain": [
       "<IPython.core.display.Javascript object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<div><table id=\"ac8937b5-7360-4bd4-b9f7-2102d42c5748\" class=\"display\"><thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Vaccine Platform</th>\n",
       "      <th>Vaccine Specifics</th>\n",
       "      <th>Company \n",
       " Developer</th>\n",
       "      <th>Trial Stage</th>\n",
       "      <th>Other Uses</th>\n",
       "    </tr>\n",
       "  </thead></table>\n",
       "<script type=\"text/javascript\">\n",
       "require([\"datatables\"], function (datatables) {\n",
       "    $(document).ready(function () {        \n",
       "        var dt_args = {\"columnDefs\": [{\"width\": \"70px\", \"targets\": \"_all\"}], \"data\": [[0, \"Non- Replicating Viral Vector\", \"Adenovirus Type 5 Vector\", \"CanSino Biological Inc. and Beijing Institute of Biotechnology\", \"Phase 1\", \"Ebola\"], [1, \"RNA\", \"LNP- encapsulated mRNA\", \"Moderna/NIAID\", \"Phase 1\", \"multiple candidates\"], [6, \"DNA\", \"DNA plasmid vaccine Electroporation device\", \"Inovio Pharmaceuticals\", \"Pre-Clinical\", \"Lassa, Nipah HIV Filovirus HPV Cancer indications Zika Hepatitis B\"], [7, \"DNA\", \"DNA\", \"Takis/Applied DNA Sciences/Evvivax\", \"Pre-Clinical\", \"nan\"], [8, \"DNA\", \"DNA plasmid vaccine\", \"Zydus Cadila\", \"Pre-Clinical\", \"nan\"], [9, \"Inactivated\", \"Formaldehyde- inactivated + alum\", \"Sinovac\", \"Pre-Clinical\", \"SARS\"], [10, \"Live Attenuated Virus\", \"Deoptimized live attanuated vaccines\", \"Codagenix/Serum Institute of India\", \"Pre-Clinical\", \"HAV, InfA, ZIKV, FMD, SIV, RSV, DENV\"], [11, \"Non- Replicating Viral Vector\", \"MVA encoded VLP\", \"GeoVax/BravoVax\", \"Pre-Clinical\", \"LASV, EBOV, MARV, HIV\"], [12, \"Non- Replicating Viral Vector\", \"Ad26 (alone or with MVA boost)\", \"Janssen Pharmaceutical Companies\", \"Pre-Clinical\", \"Ebola, HIV, RSV\"], [13, \"Non- Replicating Viral Vector\", \"ChAdOx1\", \"University of Oxford\", \"Pre-Clinical\", \"influenza, TB, Chikungunya, Zika, MenB, plague\"], [14, \"Non- Replicating Viral Vector\", \"adenovirus- based NasoVAX expressing SARS2-CoV spike protein\", \"Altimmune\", \"Pre-Clinical\", \"influenza\"], [15, \"Non- Replicating Viral Vector\", \"Ad5 S (GREVAXTM platform)\", \"Greffex\", \"Pre-Clinical\", \"MERS\"], [16, \"Non- Replicating Viral Vector\", \"Oral Vaccine platform\", \"Vaxart\", \"Pre-Clinical\", \"InfA, CHIKV, LASV, NORV; EBOV, RVF, HBV, VEE\"], [17, \"Protein Subunit\", \"Drosophila S2 insect cell expression system VLPs\", \"ExpreS2ion\", \"Pre-Clinical\", \"nan\"], [18, \"Protein Subunit\", \"S protein\", \"WRAIR/USAMRIID\", \"Pre-Clinical\", \"nan\"], [19, \"Protein Subunit\", \"S-Trimer\", \"Clover Biopharmaceuticals Inc./GSK\", \"Pre-Clinical\", \"HIV, REV Influenza\"], [20, \"Protein Subunit\", \"Peptide\", \"Vaxil Bio\", \"Pre-Clinical\", \"nan\"], [21, \"Protein Subunit\", \"S protein\", \"AJ Vaccines\", \"Pre-Clinical\", \"nan\"], [22, \"Protein Subunit\", \"Ii-Key peptide\", \"Generex/EpiVax\", \"Pre-Clinical\", \"Influenza, HIV, SARS- CoV\"], [23, \"Protein Subunit\", \"S protein\", \"EpiVax/Univ. of Georgia\", \"Pre-Clinical\", \"H7N9\"], [24, \"Protein Subunit\", \"S protein (baculovirus production)\", \"Sanofi Pasteur\", \"Pre-Clinical\", \"Influenza, SARS-CoV\"], [25, \"Protein Subunit\", \"Full length S trimers/ nanoparticle + Matrix M\", \"Novavax\", \"Pre-Clinical\", \"RSV; CCHF, HPV, VZV, EBOV\"], [26, \"Protein Subunit\", \"gp-96 backbone\", \"Heat Biologics/Univ. Of Miami\", \"Pre-Clinical\", \"NSCLC, HIV, malaria, Zika\"], [27, \"Protein Subunit\", \"Molecular clamp stabilized Spike protein\", \"University of Queensland/GSK\", \"Pre-Clinical\", \"Nipah, influenza, Ebola, Lassa\"], [28, \"Protein Subunit\", \"S1 or RBD protein\", \"Baylor College of Medicine\", \"Pre-Clinical\", \"SARS\"], [29, \"Protein Subunit\", \"Subunit protein, plant produced\", \"iBio/CC-Pharming\", \"Pre-Clinical\", \"nan\"], [30, \"Protein Subunit\", \"Subunit\", \"VIDO-InterVac, University of Saskatchewan\", \"Pre-Clinical\", \"nan\"], [31, \"Protein Subunit\", \"Adjuvanted microsphere peptide\", \"University of Saskatchewan\", \"Pre-Clinical\", \"nan\"], [32, \"Replicating Viral Vector\", \"Measles Vector\", \"Zydus Cadila\", \"Pre-Clinical\", \"nan\"], [33, \"Replicating Viral Vector\", \"Measles Vector\", \"Institute Pasteur/Themis/Univ. of Pittsburg Center for Vaccine Research\", \"Pre-Clinical\", \"West nile, chik, Ebola, Lassa, Zika\"], [34, \"Replicating Viral Vector\", \"Horsepox vector expressing S protein\", \"Tonix Pharma/Southern Research\", \"Pre-Clinical\", \"Smallpox, monkeypox\"], [35, \"RNA\", \"LNP- encapsulated mRNA  cocktail encoding VLP\", \"Fudan University/ Shanghai JiaoTong University/RNACure Biopharma\", \"Pre-Clinical\", \"nan\"], [36, \"RNA\", \"LNP- encapsulated mRNA encoding RBD\", \"Fudan University/ Shanghai JiaoTong University/RNACure Biopharma\", \"Pre-Clinical\", \"nan\"], [37, \"RNA\", \"mRNA\", \"China CDC/Tongji University/Stermina\", \"Pre-Clinical\", \"nan\"], [38, \"RNA\", \"mRNA\", \"Arcturus/Duke-NUS\", \"Pre-Clinical\", \"multiple candidates\"], [39, \"RNA\", \"mRNA\", \"BioNTech/Fosun Pharma/Pfizer\", \"Pre-Clinical\", \"nan\"], [40, \"RNA\", \"saRNA\", \"Imperial College London\", \"Pre-Clinical\", \"EBOV; LASV, MARV, Inf (H7N9), RABV\"], [41, \"RNA\", \"mRNA\", \"Curevac\", \"Pre-Clinical\", \"RABV, LASV, YFV; MERS, InfA, ZIKV, DengV, NIPV\"], [42, \"VLP\", \"Plant-derived VLP\", \"Medicago Inc.\", \"Pre-Clinical\", \"Flu, Rotavirus, Norovirus, West Nile virus, Cancer\"], [43, \"Unknown\", \"Unknown\", \"University of Hong Kong\", \"Pre-Clinical\", \"nan\"], [44, \"Unknown\", \"Unknown\", \"ImmunoPrecise\", \"Pre-Clinical\", \"nan\"], [45, \"Unknown\", \"Unknown\", \"MIGAL Galilee Research Institute\", \"Pre-Clinical\", \"nan\"], [46, \"Unknown\", \"Unknown\", \"Doherty Institute\", \"Pre-Clinical\", \"nan\"], [47, \"Unknown\", \"Unknown\", \"Tulane University\", \"Pre-Clinical\", \"nan\"]]};\n",
       "        dt_args = eval_functions(dt_args);\n",
       "        table = $('#ac8937b5-7360-4bd4-b9f7-2102d42c5748').DataTable(dt_args);\n",
       "    });\n",
       "})\n",
       "</script>\n",
       "</div>\n"
      ],
      "text/plain": [
       "                 Vaccine Platform  \\\n",
       "0   Non- Replicating Viral Vector   \n",
       "1                             RNA   \n",
       "6                             DNA   \n",
       "7                             DNA   \n",
       "8                             DNA   \n",
       "9                     Inactivated   \n",
       "10          Live Attenuated Virus   \n",
       "11  Non- Replicating Viral Vector   \n",
       "12  Non- Replicating Viral Vector   \n",
       "13  Non- Replicating Viral Vector   \n",
       "14  Non- Replicating Viral Vector   \n",
       "15  Non- Replicating Viral Vector   \n",
       "16  Non- Replicating Viral Vector   \n",
       "17                Protein Subunit   \n",
       "18                Protein Subunit   \n",
       "19                Protein Subunit   \n",
       "20                Protein Subunit   \n",
       "21                Protein Subunit   \n",
       "22                Protein Subunit   \n",
       "23                Protein Subunit   \n",
       "24                Protein Subunit   \n",
       "25                Protein Subunit   \n",
       "26                Protein Subunit   \n",
       "27                Protein Subunit   \n",
       "28                Protein Subunit   \n",
       "29                Protein Subunit   \n",
       "30                Protein Subunit   \n",
       "31                Protein Subunit   \n",
       "32       Replicating Viral Vector   \n",
       "33       Replicating Viral Vector   \n",
       "34       Replicating Viral Vector   \n",
       "35                            RNA   \n",
       "36                            RNA   \n",
       "37                            RNA   \n",
       "38                            RNA   \n",
       "39                            RNA   \n",
       "40                            RNA   \n",
       "41                            RNA   \n",
       "42                            VLP   \n",
       "43                        Unknown   \n",
       "44                        Unknown   \n",
       "45                        Unknown   \n",
       "46                        Unknown   \n",
       "47                        Unknown   \n",
       "\n",
       "                                    Vaccine Specifics  \\\n",
       "0                            Adenovirus Type 5 Vector   \n",
       "1                              LNP- encapsulated mRNA   \n",
       "6          DNA plasmid vaccine Electroporation device   \n",
       "7                                                 DNA   \n",
       "8                                 DNA plasmid vaccine   \n",
       "9                    Formaldehyde- inactivated + alum   \n",
       "10               Deoptimized live attanuated vaccines   \n",
       "11                                    MVA encoded VLP   \n",
       "12                     Ad26 (alone or with MVA boost)   \n",
       "13                                            ChAdOx1   \n",
       "14  adenovirus- based NasoVAX expressing SARS2-CoV...   \n",
       "15                          Ad5 S (GREVAXTM platform)   \n",
       "16                              Oral Vaccine platform   \n",
       "17   Drosophila S2 insect cell expression system VLPs   \n",
       "18                                          S protein   \n",
       "19                                           S-Trimer   \n",
       "20                                            Peptide   \n",
       "21                                          S protein   \n",
       "22                                     Ii-Key peptide   \n",
       "23                                          S protein   \n",
       "24                 S protein (baculovirus production)   \n",
       "25     Full length S trimers/ nanoparticle + Matrix M   \n",
       "26                                     gp-96 backbone   \n",
       "27           Molecular clamp stabilized Spike protein   \n",
       "28                                  S1 or RBD protein   \n",
       "29                    Subunit protein, plant produced   \n",
       "30                                            Subunit   \n",
       "31                     Adjuvanted microsphere peptide   \n",
       "32                                     Measles Vector   \n",
       "33                                     Measles Vector   \n",
       "34               Horsepox vector expressing S protein   \n",
       "35      LNP- encapsulated mRNA  cocktail encoding VLP   \n",
       "36                LNP- encapsulated mRNA encoding RBD   \n",
       "37                                               mRNA   \n",
       "38                                               mRNA   \n",
       "39                                               mRNA   \n",
       "40                                              saRNA   \n",
       "41                                               mRNA   \n",
       "42                                  Plant-derived VLP   \n",
       "43                                            Unknown   \n",
       "44                                            Unknown   \n",
       "45                                            Unknown   \n",
       "46                                            Unknown   \n",
       "47                                            Unknown   \n",
       "\n",
       "                                 Company \\n Developer   Trial Stage  \\\n",
       "0   CanSino Biological Inc. and Beijing Institute ...       Phase 1   \n",
       "1                                       Moderna/NIAID       Phase 1   \n",
       "6                              Inovio Pharmaceuticals  Pre-Clinical   \n",
       "7                  Takis/Applied DNA Sciences/Evvivax  Pre-Clinical   \n",
       "8                                        Zydus Cadila  Pre-Clinical   \n",
       "9                                             Sinovac  Pre-Clinical   \n",
       "10                 Codagenix/Serum Institute of India  Pre-Clinical   \n",
       "11                                    GeoVax/BravoVax  Pre-Clinical   \n",
       "12                   Janssen Pharmaceutical Companies  Pre-Clinical   \n",
       "13                               University of Oxford  Pre-Clinical   \n",
       "14                                          Altimmune  Pre-Clinical   \n",
       "15                                            Greffex  Pre-Clinical   \n",
       "16                                             Vaxart  Pre-Clinical   \n",
       "17                                         ExpreS2ion  Pre-Clinical   \n",
       "18                                     WRAIR/USAMRIID  Pre-Clinical   \n",
       "19                 Clover Biopharmaceuticals Inc./GSK  Pre-Clinical   \n",
       "20                                          Vaxil Bio  Pre-Clinical   \n",
       "21                                        AJ Vaccines  Pre-Clinical   \n",
       "22                                     Generex/EpiVax  Pre-Clinical   \n",
       "23                            EpiVax/Univ. of Georgia  Pre-Clinical   \n",
       "24                                     Sanofi Pasteur  Pre-Clinical   \n",
       "25                                            Novavax  Pre-Clinical   \n",
       "26                      Heat Biologics/Univ. Of Miami  Pre-Clinical   \n",
       "27                       University of Queensland/GSK  Pre-Clinical   \n",
       "28                         Baylor College of Medicine  Pre-Clinical   \n",
       "29                                   iBio/CC-Pharming  Pre-Clinical   \n",
       "30          VIDO-InterVac, University of Saskatchewan  Pre-Clinical   \n",
       "31                         University of Saskatchewan  Pre-Clinical   \n",
       "32                                       Zydus Cadila  Pre-Clinical   \n",
       "33  Institute Pasteur/Themis/Univ. of Pittsburg Ce...  Pre-Clinical   \n",
       "34                     Tonix Pharma/Southern Research  Pre-Clinical   \n",
       "35  Fudan University/ Shanghai JiaoTong University...  Pre-Clinical   \n",
       "36  Fudan University/ Shanghai JiaoTong University...  Pre-Clinical   \n",
       "37               China CDC/Tongji University/Stermina  Pre-Clinical   \n",
       "38                                  Arcturus/Duke-NUS  Pre-Clinical   \n",
       "39                       BioNTech/Fosun Pharma/Pfizer  Pre-Clinical   \n",
       "40                            Imperial College London  Pre-Clinical   \n",
       "41                                            Curevac  Pre-Clinical   \n",
       "42                                      Medicago Inc.  Pre-Clinical   \n",
       "43                            University of Hong Kong  Pre-Clinical   \n",
       "44                                      ImmunoPrecise  Pre-Clinical   \n",
       "45                   MIGAL Galilee Research Institute  Pre-Clinical   \n",
       "46                                  Doherty Institute  Pre-Clinical   \n",
       "47                                  Tulane University  Pre-Clinical   \n",
       "\n",
       "                                           Other Uses  \n",
       "0                                               Ebola  \n",
       "1                                 multiple candidates  \n",
       "6   Lassa, Nipah HIV Filovirus HPV Cancer indicati...  \n",
       "7                                                 NaN  \n",
       "8                                                 NaN  \n",
       "9                                                SARS  \n",
       "10               HAV, InfA, ZIKV, FMD, SIV, RSV, DENV  \n",
       "11                              LASV, EBOV, MARV, HIV  \n",
       "12                                    Ebola, HIV, RSV  \n",
       "13     influenza, TB, Chikungunya, Zika, MenB, plague  \n",
       "14                                          influenza  \n",
       "15                                               MERS  \n",
       "16       InfA, CHIKV, LASV, NORV; EBOV, RVF, HBV, VEE  \n",
       "17                                                NaN  \n",
       "18                                                NaN  \n",
       "19                                 HIV, REV Influenza  \n",
       "20                                                NaN  \n",
       "21                                                NaN  \n",
       "22                          Influenza, HIV, SARS- CoV  \n",
       "23                                               H7N9  \n",
       "24                                Influenza, SARS-CoV  \n",
       "25                          RSV; CCHF, HPV, VZV, EBOV  \n",
       "26                          NSCLC, HIV, malaria, Zika  \n",
       "27                     Nipah, influenza, Ebola, Lassa  \n",
       "28                                               SARS  \n",
       "29                                                NaN  \n",
       "30                                                NaN  \n",
       "31                                                NaN  \n",
       "32                                                NaN  \n",
       "33                West nile, chik, Ebola, Lassa, Zika  \n",
       "34                                Smallpox, monkeypox  \n",
       "35                                                NaN  \n",
       "36                                                NaN  \n",
       "37                                                NaN  \n",
       "38                                multiple candidates  \n",
       "39                                                NaN  \n",
       "40                 EBOV; LASV, MARV, Inf (H7N9), RABV  \n",
       "41     RABV, LASV, YFV; MERS, InfA, ZIKV, DengV, NIPV  \n",
       "42  Flu, Rotavirus, Norovirus, West Nile virus, Ca...  \n",
       "43                                                NaN  \n",
       "44                                                NaN  \n",
       "45                                                NaN  \n",
       "46                                                NaN  \n",
       "47                                                NaN  "
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Show an interactive dataframe table\n",
    "import itables.interactive\n",
    "df"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## COVID-19 Treatment Options in Development"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [],
   "source": [
    "# load the data\n",
    "url = 'https://milkeninstitute.org/sites/default/files/2020-03/Covid19-Tracker-3-36-20-FINAL.pdf'\n",
    "\n",
    "#url = 'https://www.who.int/blueprint/priority-diseases/key-action/novel-coronavirus-landscape-ncov.pdf?ua=1'\n",
    "\n",
    "myfile = requests.get(url)\n",
    "open('COVID19-data2.pdf', 'wb').write(myfile.content)\n",
    "\n",
    "#declare the path of your file\n",
    "file_path = \"COVID19-data2.pdf\"\n",
    "#Convert your file\n",
    "df = tabula.read_pdf(file_path, pages='all', lattice=True,multiple_tables=True)\n",
    "#df = df[10]\n",
    "#df = df.drop(index=0)\n",
    "#df = df[0]\n",
    "#df = df.dropna(axis=0,thresh=5)\n",
    "\n",
    "\n",
    "\n",
    "for i in range(len(df)):\n",
    "    temp_df = df[i]\n",
    "    if temp_df.shape[1] == 9:\n",
    "        if 'df_all' in locals():\n",
    "            df_all = df_all.append(temp_df)\n",
    "        else:\n",
    "            df_all = temp_df\n",
    "        \n",
    "df_all = df_all.dropna(axis=0, thresh=5)\n",
    "df_all = df_all.dropna(axis=1, how='all')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [],
   "source": [
    "# prepare the data\n",
    "#%% Remove the control characters\n",
    "cols = list(df_all.columns)\n",
    "for i in range(len(cols)):\n",
    "    list_a = df_all[cols[i]].values\n",
    "    for j in range(len(list_a)):\n",
    "        if isinstance(list_a[j], str) and ('\\r' in list_a[j]):\n",
    "            list_a[j] = list_a[j].replace('\\r',' ')\n",
    "        if isinstance(list_a[j], str) and ('*' in list_a[j]):\n",
    "            list_a[j] = list_a[j].replace('*','')\n",
    "        \n",
    "    df_all[cols[i]] = list_a\n",
    "\n",
    "for i in range(len(cols)):\n",
    "    if isinstance(cols[i], str) and ('\\r' in cols[i]):\n",
    "        cols[i] = cols[i].replace('\\r',' ')\n",
    "    if isinstance(cols[i], str) and ('*' in cols[i]):\n",
    "        cols[i] = cols[i].replace('*','')\n",
    "    \n",
    "df_all.columns = cols"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### COVID-19 Treatment Options (Top 5 Pursued Approaches)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 600x400 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "plat_count = df_all['Type of Product - Treatment'].value_counts()\n",
    "n_plot = 5\n",
    "chart = sns.barplot(plat_count[:n_plot].index, plat_count[:n_plot].values, alpha=0.8,palette=\"ch:.25\")\n",
    "plt.setp(chart.get_xticklabels(), rotation=90)\n",
    "plt.xlabel('Top '+ str(n_plot)+' Treatment Approaches Being Pursued')\n",
    "plt.ylabel('Count')\n",
    "chart.spines['top'].set_visible(False)\n",
    "chart.spines['right'].set_visible(False)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Treatment Trial Phase"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {
    "scrolled": false
   },
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 600x400 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "plat_count = df_all['Current Stage of Development'].value_counts()\n",
    "chart = sns.barplot(plat_count.index, plat_count.values, alpha=0.8,palette=\"ch:.25\")\n",
    "plt.setp(chart.get_xticklabels(), rotation=45)\n",
    "plt.xlabel('Stage of Development for All Treatments')\n",
    "plt.ylabel('Count')\n",
    "chart.spines['top'].set_visible(False)\n",
    "chart.spines['right'].set_visible(False)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Treatment Clinical Trial Phases and Months"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [],
   "source": [
    "#%% Get the dates for the clinical trials\n",
    "\n",
    "phases = []\n",
    "dates = []\n",
    "timing = df_all['Anticipated Next Steps Timing'].values\n",
    "for i in range(len(timing)):\n",
    "    if isinstance(timing[i], str) and ('Phase 1' in timing[i]):\n",
    "        phases.append('Phase 1')\n",
    "    elif isinstance(timing[i], str) and ('Phase 2' in timing[i]):\n",
    "        phases.append('Phase 2')\n",
    "    else:\n",
    "        phases.append(np.nan)\n",
    "\n",
    "\n",
    "months = ['January','February', 'March', 'April', 'May', 'June', 'July', 'August',\n",
    "          'September', 'October', 'November', 'December']\n",
    "for i in range(len(timing)):\n",
    "    for j in range(len(months)):\n",
    "        if isinstance(timing[i], str) and (months[j] in timing[i]):\n",
    "            dates.append(months[j])\n",
    "    if len(dates)<i+1:\n",
    "        dates.append(np.nan)\n",
    "\n",
    "df_all2 = df_all.copy()\n",
    "df_all2['dates'] = dates\n",
    "df_all2['phases'] = phases"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 600x400 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 600x400 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "#%%\n",
    "\n",
    "plat_count = df_all2['phases'].value_counts()\n",
    "chart = sns.barplot(plat_count.index, plat_count.values, alpha=0.8,palette=\"ch:.25\")\n",
    "plt.setp(chart.get_xticklabels(), rotation=45)\n",
    "plt.xlabel('Phases of Clinical Trials')\n",
    "plt.ylabel('Count')\n",
    "chart.spines['top'].set_visible(False)\n",
    "chart.spines['right'].set_visible(False)  \n",
    "\n",
    "#%%\n",
    "plt.figure()\n",
    "plat_count = df_all2['dates'].value_counts()\n",
    "chart = sns.barplot(plat_count.index, plat_count.values, alpha=0.8,palette=\"ch:.25\", order=months)\n",
    "plt.setp(chart.get_xticklabels(), rotation=45)\n",
    "plt.xlabel('Months of Clinical Trials')\n",
    "plt.ylabel('Count')\n",
    "chart.spines['top'].set_visible(False)\n",
    "chart.spines['right'].set_visible(False)  \n",
    "\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Treatment Data"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div><table id=\"220c6231-056c-4f32-bbdd-dac776807ef9\" class=\"display\"><thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Number</th>\n",
       "      <th>Type of Product - Treatment</th>\n",
       "      <th>FDA-Approved Indications</th>\n",
       "      <th>Developer/Researcher</th>\n",
       "      <th>Current Stage of Development</th>\n",
       "      <th>Funding Sources</th>\n",
       "      <th>Anticipated Next Steps Timing</th>\n",
       "      <th>Sources</th>\n",
       "      <th>FDA-Approved Indications (Treatments)</th>\n",
       "      <th>Clinical Trials Ongoing for Other Diseases</th>\n",
       "      <th>Developer/ Researcher</th>\n",
       "    </tr>\n",
       "  </thead></table>\n",
       "<script type=\"text/javascript\">\n",
       "require([\"datatables\"], function (datatables) {\n",
       "    $(document).ready(function () {        \n",
       "        var dt_args = {\"columnDefs\": [{\"width\": \"70px\", \"targets\": \"_all\"}], \"data\": [[1, \"1\", \"TAK-888, antibodies from recovered COVID-19\", \"N/A\", \"Takeda\", \"Pre-clinical\", \"nan\", \"To patients between September 2020 and September 2021\", \"PhRMA Wall Street Journal\", \"nan\", \"nan\", \"nan\"], [3, \"2\", \"Antibodies from mice, REGN3048-3051, against the spike protein\", \"N/A\", \"Regeneron\", \"Pre-clinical\", \"Biomedical Advanced Research and Development Authority (BARDA)\", \"Start Phase 1 June 2020\", \"Stat News MarketWatch Reuters Bloomberg News FierceBiotech FiercePharma\", \"nan\", \"nan\", \"nan\"], [4, \"3\", \"Antibodies from recovered COVID-19 patients\", \"N/A\", \"Celltrion\", \"Pre-clinical\", \"nan\", \"Start Phase 1 September 2020\", \"Korea Herald\", \"nan\", \"nan\", \"nan\"], [5, \"4\", \"Antibodies from recovered COVID-19 patients\", \"N/A\", \"Kamada\", \"Pre-clinical\", \"nan\", \"nan\", \"BioSpace AbbVie\", \"nan\", \"nan\", \"nan\"], [6, \"5\", \"Antibodies from recovered COVID-19 patients\", \"N/A\", \"Vir Biotech/WuXi Biologics/Biogen\", \"Pre-clinical\", \"nan\", \"Start Phase 1 ~ July 2020\", \"Stat News Vir Biotech\", \"nan\", \"nan\", \"nan\"], [7, \"6\", \"Antibodies from recovered COVID-19 patients\", \"N/A\", \"Lilly/Ab-Cellera (NIH Vaccines Research Center)\", \"Pre-clinical\", \"nan\", \"Start Phase 1 in late July 2020\", \"Endpoints News\", \"nan\", \"nan\", \"nan\"], [8, \"7\", \"Avastin (bevacizumab), vascular endothelial growth factor inhibitor\", \"FDA-approved since 2004, approved to treat certain types of cancer\", \"Numerous trials with Chinese research sponsors; Roche\", \"Clinical\", \"nan\", \"nan\", \"BioCentury ClinicalTrials.gov\", \"nan\", \"nan\", \"nan\"], [9, \"8\", \"PD-1 blocking antibody; Thymosin\", \"Unknown\", \"Numerous trials with Chinese research sponsors\", \"Clinical\", \"nan\", \"Phase 2 primary trial ends April 30, 2020\", \"BioCentury ClinicalTrials.gov\", \"nan\", \"nan\", \"nan\"], [0, \"9\", \"leronlimab (PRO 140), a CCR5 antagonist\", \"nan\", \"CytoDyn\", \"Clinical\", \"nan\", \"nan\", \"Clinical Trials Arena CytoDyn CytoDyn CytoDyn CytoDyn\", \"N/A\", \"Treatment of HIV/ AIDS, Graft versus Host Disease, Non-Alcoholic Steatohepatitis, and numerous cancers\", \"nan\"], [1, \"10\", \"AiRuiKa (camrelizumab), anti-programmed cell death\", \"nan\", \"Wuhan Jinyintan Hospital\", \"Clinical\", \"nan\", \"\", \"Hengrui Medicine\", \"N/A\", \"Treatment of certain\", \"nan\"], [3, \"11\", \"Kevzara (sarilumab), interleukin-6 receptor antagonist\", \"nan\", \"Sanofi/Regeneron\", \"Clinical\", \"nan\", \"Started Phase 2/3 in March 2020\", \"FiercePharma Wall Street Journal Seeking Alpha\", \"FDA-approved since 2017, approved to treat rheumatoid arthritis\", \"nan\", \"nan\"], [4, \"12\", \"Actemra (tocilizumab), interleukin-6 receptor antagonist\", \"nan\", \"Numerous trials with global research sponsors; Roche\", \"Clinical\", \"nan\", \"Roche studies begin April 2020\", \"Wall Street Journal FiercePharma Genentech\", \"FDA-approved since 2010, approved to treat various type of arthritis, including rheumatoid arthritis, and cytokine release syndrome\", \"nan\", \"nan\"], [5, \"13\", \"Gimsilumab, anti- granulocyte-macrophage colony stimulating factor monoclonal\", \"nan\", \"Roivant Sciences\", \"Clinical\", \"nan\", \"nan\", \"Roivant\", \"N/A\", \"nan\", \"nan\"], [6, \"14\", \"TJM2 (TJ003234), anti- granulocyte-macrophage colony stimulating factor antibody\", \"nan\", \"I-Mab Biopharma\", \"Clinical\", \"nan\", \"nan\", \"i-Mab Biopharma\", \"N/A\", \"nan\", \"nan\"], [7, \"15\", \"Sylvant (siltuximab), interleukin-6 targeted monoclonal\", \"nan\", \"EUSA Pharma/The Papa Giovanni XXII Hospital\", \"Clinical\", \"nan\", \"Initial data March 2020\", \"EUSA Pharma\", \"FDA-approved since 2014, approved to treat multicentric Castleman disease\", \"nan\", \"nan\"], [8, \"16\", \"Soliris (eculizumaab), complement inhibitor\", \"nan\", \"Alexion\", \"Expanded access\", \"nan\", \"nan\", \"Alexion\", \"FDA-approved since 2007, approved to treat Paroxysmal Nocturnal Hemoglobinuria, Atypical Hemolytic Uremic Syndrome, Generalized Myasthenia Gravis, and Neuromyelitis Optica Spectrum Disorder\", \"nan\", \"nan\"], [0, \"17\", \"Antibody\", \"nan\", \"Erasmus MC/Utrecht University\", \"Pre-clinical\", \"nan\", \"nan\", \"Erasmus Magazine bioRxiv\", \"N/A\", \"nan\", \"nan\"], [1, \"18\", \"Antibodies\", \"nan\", \"ImmunoPrecise Antibodies\", \"Pre-clinical\", \"nan\", \"nan\", \"Clinical Trials Arena\", \"Unknown\", \"nan\", \"nan\"], [2, \"19\", \"Antibody\", \"nan\", \"Harbour BioMed/Mount Sinai Health System\", \"Pre-clinical\", \"nan\", \"nan\", \"Mount Sinai and Harbour BioMed press release\", \"N/A\", \"nan\", \"nan\"], [3, \"20\", \"Antibodies\", \"nan\", \"AstraZeneca\", \"Pre-clinical\", \"nan\", \"nan\", \"PhRMA\", \"Unknown\", \"nan\", \"nan\"], [4, \"21\", \"Antibody\", \"nan\", \"Distributed Bio\", \"Pre-clinical\", \"nan\", \"nan\", \"Distributed Bio\", \"Unknown\", \"nan\", \"nan\"], [5, \"22\", \"Antibodies\", \"nan\", \"Chelsea and Westminster Hospital, Imperial College London\", \"Pre-clinical\", \"UK Government\", \"nan\", \"UK Government\", \"Unknown\", \"nan\", \"nan\"], [6, \"23\", \"Convalescent plasma (blood plasma from recovered patients)\", \"nan\", \"Multiple global research sponsors, including New York State Department of Health\", \"Clinical\", \"nan\", \"New York State Department of Health trial begins March 2020\", \"Politico\", \"N/A\", \"nan\", \"nan\"], [8, \"24\", \"Favilavir/Favipiravir/T-705/ Avigan, licensed in Japan to treat influenza\", \"nan\", \"Fujifilm Toyama Chemical/Zhejiang Hisun Pharmaceuticals/numerous trials with Chinese research sponsors\", \"Clinical\", \"nan\", \"nan\", \"World Health Organization Clinical Trials Arena Pharmaceutical Technology Chinese Clinical Trial Registry ClinicalTrials.gov BioCentury Guardian Chinese Clinical Trial Registry Chinese Clinical Trial Registry Chinese Clinical Trial Registry Chinese Clinical Trial Registry Chinese Clinical Trial Registry Chinese Clinical Trial Registry Chinese Clinical Trial Registry Chinese Clinical Trial Registry\", \"N/A\", \"nan\", \"nan\"], [0, \"25\", \"Kaletra/Aluvia (lopinavir/ ritonavir), HIV-1 protease inhibitor\", \"nan\", \"Global hospital testing (AbbVie); World Health Organization SOLIDARITY trial (studying lopinavir/ ritonavir with and without interferon beta); University of Oxford\", \"Clinical\", \"UK Government (University of Oxford RECOVERY trial)\", \"nan\", \"PhRMA Wall Street Journal Wall Street Journal Wall Street Journal Stat News\", \"FDA-approved since 2000, approved to treat HIV-1 infection\", \"nan\", \"nan\"], [1, \"26\", \"remdesivir, nucleotide analog\", \"nan\", \"Gilead; World Health Organization SOLIDARITY trial\", \"Clinical\", \"nan\", \"Gilead Phase 3 trial results expected April 2020\", \"PhRMA Wall Street Journal PhRMA post on LinkedIn Stat News\", \"N/A\", \"Treatment of Ebola\", \"nan\"], [2, \"27\", \"Prezcobix (darunavir, HIV-1 protease inhibitor/cobicistat, CYP3A inhibitor)\", \"nan\", \"Chinese hospital testing (Janssen)\", \"Clinical\", \"nan\", \"Primary study ends August 2020\", \"World Health Organization Wall Street Journal Chinese Clinical Trial Registry ClinicalTrials.gov\", \"FDA-approved since 2015, approved to treat HIV-1 infection\", \"nan\", \"nan\"], [3, \"28\", \"galidesivir\", \"nan\", \"BioCryst Pharmaceuticals\", \"Pre-clinical\", \"nan\", \"nan\", \"Reuters BioCryst\", \"N/A\", \"Treatment of yellow fever\", \"nan\"], [4, \"29\", \"Combination of ebastine, lopinavir, and interferon alpha\", \"nan\", \"Mianyang Central Hospital\", \"Clinical\", \"nan\", \"Primary trial ends March 31, 2020\", \"BioCentury Chinese Clinical Trial Registry\", \"N/A\", \"nan\", \"nan\"], [5, \"30\", \"Ganovo (danoprevir), hepatitis C virus NS3 protease inhibitor; ritonavir; interferon, approved in China to treat Hepatitis C\", \"nan\", \"Ascletis/Numerous trials with Chinese research sponsors\", \"Clinical\", \"nan\", \"nan\", \"BioCentury ClinicalTrials.gov\", \"N/A\", \"nan\", \"nan\"], [6, \"31\", \"ASC09, HIV protease inhibitor\", \"nan\", \"Ascletis Pharma\", \"Clinical\", \"nan\", \"Primary trial ends May 2020\", \"ClinicalTrials.gov Nature Biotechnology Ascletis Pharma\", \"N/A\", \"Treatment of HIV/AIDS\", \"nan\"], [7, \"32\", \"Truvada (emtricitabine and tenofovir, both HIV-1 nucleoside analog reverse transcriptase inhibitors)\", \"nan\", \"Gilead/Sichuan Academy of Medical Sciences & Sichuan Provincial People\\u2019s Hospital\", \"Clinical\", \"nan\", \"nan\", \"World Health Organization Chinese Clinical Trial Registry\", \"FDA-approved since 2004, approved to treat and prevent HIV-1 infection\", \"nan\", \"nan\"], [0, \"33\", \"Arbidol (umifenovir), licensed in Russia and China for treatment of respiratory viral infections\", \"nan\", \"nan\", \"Clinical\", \"nan\", \"nan\", \"World Health Organization BioCentury ClinicalTrials.gov Chinese Clinical Trial Registry Chinese Clinical Trial Registry\", \"N/A\", \"nan\", \"Pharmstandard/numerous trials with Chinese research sponsors\"], [1, \"34\", \"Xofluza (baloxavir marboxil), polymerase acidic endonuclease inhibitor\", \"nan\", \"nan\", \"Clinical\", \"nan\", \"nan\", \"World Health Organization Chinese Clinical Trial Registry\", \"FDA-approved since 2018, approved to treat influenza\", \"nan\", \"Roche/The First Affiliated Hospital of Zhejiang University Medical School\"], [2, \"35\", \"azvudine, reverse transcriptase inhibitor\", \"nan\", \"nan\", \"Clinical\", \"nan\", \"nan\", \"World Health Organization Chinese Clinical Trial Registry\", \"N/A\", \"nan\", \"Numerous trials with Chinese research sponsors\"], [3, \"36\", \"ISR-50\", \"nan\", \"nan\", \"Pre-clinical\", \"nan\", \"nan\", \"ISR Immune System Regulation\", \"N/A\", \"nan\", \"ISR Immune System Regulation\"], [4, \"37\", \"Antiviral compounds\", \"nan\", \"nan\", \"Pre-clinical\", \"nan\", \"nan\", \"Cocrystal Pharma\", \"N/A\", \"nan\", \"Cocrystal Pharma\"], [6, \"38\", \"PLX cell product, placenta- based cell therapy\", \"nan\", \"nan\", \"Pre-clinical\", \"nan\", \"nan\", \"Pharmaceutical Technology Pluristem Therapeutics\", \"Unknown\", \"nan\", \"Pluristem Therapeutics/BIH Center for Regenerative Therapy/Berlin Center for Advanced Therapies\"], [7, \"39\", \"Mesenchymal stem cells\", \"nan\", \"nan\", \"Clinical\", \"nan\", \"nan\", \"BioCentury Chinese Clinical Trial Registry\", \"Unknown\", \"nan\", \"Numerous trials with global research sponsors\"], [8, \"40\", \"Ryoncil (remestemcel-L), allogenic mesenchymal stem cells\", \"nan\", \"nan\", \"Pre-clinical\", \"nan\", \"nan\", \"FierceBiotech\", \"N/A\", \"nan\", \"Mesoblast\"], [9, \"41\", \"MultiStem, bone marrow stem cells\", \"nan\", \"nan\", \"Clinical\", \"nan\", \"nan\", \"BioSpace\", \"nan\", \"Acute Respiratory Distress Syndrome; Stroke\", \"Athersys\"], [10, \"42\", \"Allogeneic T-cell therapies\", \"nan\", \"nan\", \"Pre-clinical\", \"nan\", \"nan\", \"AlloVir FierceBiotech\", \"N/A\", \"nan\", \"AlloVir/Baylor College of Medicine\"], [12, \"43\", \"RNAi - testing 150 RNAis\", \"nan\", \"nan\", \"Pre-clinical\", \"nan\", \"nan\", \"NPR\", \"N/A\", \"nan\", \"Sirnaomics\"], [13, \"44\", \"siRNA candidates\", \"nan\", \"nan\", \"Pre-clinical\", \"nan\", \"nan\", \"Clinical Trials Arena\", \"N/A\", \"nan\", \"Vir Biotech/Alnylam Pharmaceuticals\"], [14, \"45\", \"Ampligen; (rintatolimod)\", \"nan\", \"nan\", \"Pre-clinical\", \"nan\", \"nan\", \"nan\", \"N/A\", \"nan\", \"AIM ImmunoTech/National Institute of Infectious Diseases in Japan\"], [0, \"46\", \"OT-101, a TGF-Beta antisense drug candidate\", \"nan\", \"nan\", \"Pre-clinical\", \"nan\", \"nan\", \"Clinical Trials Arena Mateon Therapeutics\", \"N/A\", \"Various cancers\", \"Mateon Therapeutics\"], [2, \"47\", \"Scanning library of antiviral compounds\", \"nan\", \"nan\", \"Pre-clinical\", \"Biomedical Advanced Research and Development Authority (BARDA)\", \"nan\", \"Johnson & Johnson PhRMA\", \"N/A\", \"N/A\", \"Janssen Pharmaceutical Companies\"], [3, \"48\", \"Scanning compounds to repurpose\", \"nan\", \"nan\", \"Pre-clinical\", \"nan\", \"nan\", \"PhRMA\", \"N/A\", \"N/A\", \"Novartis\"], [4, \"49\", \"Scanning antiviral compounds previously in development\", \"nan\", \"nan\", \"Pre-clinical\", \"nan\", \"Screening completed March 2020, start Phase 1 by end of 2020\", \"Pfizer PhRMA\", \"N/A\", \"N/A\", \"Pfizer\"], [5, \"50\", \"Scanning compounds to repurpose\", \"nan\", \"nan\", \"Pre-clinical\", \"nan\", \"nan\", \"Wall Street Journal\", \"N/A\", \"N/A\", \"Merck\"], [6, \"51\", \"Repurposing antiviral drug candidates\", \"nan\", \"nan\", \"Pre-clinical\", \"nan\", \"nan\", \"Cyclica press release\", \"N/A\", \"N/A\", \"Materia Medica/Cyclica\"], [7, \"52\", \"Screening new drugs + library of antiviral compounds\", \"nan\", \"nan\", \"Pre-clinical\", \"nan\", \"nan\", \"FierceBiotech Enanta Pharmaceuticals\", \"N/A\", \"N/A\", \"Enanta Pharmaceuticals\"], [8, \"53\", \"Screening drug compounds\", \"nan\", \"nan\", \"Pre-clinical\", \"nan\", \"nan\", \"Clinical Trials Arena\", \"N/A\", \"N/A\", \"Southwest Research Institute\"], [9, \"54\", \"Scanning compounds to repurpose\", \"nan\", \"nan\", \"Pre-clinical\", \"nan\", \"nan\", \"PhRMA\", \"N/A\", \"N/A\", \"Takeda\"], [10, \"55\", \"Scanning compounds to repurpose\", \"nan\", \"nan\", \"Pre-clinical\", \"UK Government\", \"nan\", \"nan\", \"N/A\", \"N/A\", \"Queens University Belfast\"], [12, \"56\", \"Methylprednisolone / corticosteroids\", \"nan\", \"nan\", \"Clinical\", \"UK Government (University of Oxford RECOVERY trial)\", \"Primary study ends April 2020 (Peking) / June 2020 (Tongji)\", \"nan\", \"FDA-approved since at least the 1950s, approved to treat many diseases, including anti-inflammatory conditions and some cancers\", \"nan\", \"Numerous trials with research sponsors in China; University of Oxford\"], [0, \"57\", \"Chloroquine/ Hydroxychloroquine, antimalarial\", \"nan\", \"Numerous trials with global research sponsors; University of Minnesota; University of Oxford; IHU-M\\u00e9diterran\\u00e9e Infection and others; World Health Organization SOLIDARITY trial (chloroquine); New York State Department of Health (hydroxychloroquine with zithromax)\", \"Clinical\", \"nan\", \"nan\", \"World Health Organization ClinicalTrials.gov BioCentury Endpoints News ClinicalTrials.gov Google Doc Stat News ClinicalTrials.gov\", \"FDA-approved since 1949, approved to treat malaria (chloroquine), FDA-approved since at least 1955, approved to treat malaria, rheumatoid arthritis, and lupus (hydroxychloroquine)\", \"nan\", \"nan\"], [1, \"58\", \"Camostat mesylate, transmembrane protease serine 2 (TMPRSS2) inhibitor, approved in Japan to treat multiple conditions including\", \"nan\", \"Leibniz Institute for Primate Research/University G\\u00f6ttingen and others\", \"Pre-clinical\", \"nan\", \"nan\", \"Nature Biotechnology bioRxiv Thailand Medical News Cell\", \"N/A\", \"nan\", \"nan\"], [3, \"59\", \"Jakafi/jakavi (ruxolitinib)\", \"nan\", \"Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology/Incyte Corp\", \"Clinical\", \"nan\", \"nan\", \"World Health Organization Chinese Clinical Trial Registry\", \"FDA-approved since 2011, approved to treat myelofibrosis, polycythemia vera, and acute graft- versus-host disease\", \"nan\", \"nan\"], [4, \"60\", \"PegIntron, Sylatron, IntronA (peginterferon alfa-2b)\", \"nan\", \"Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital) (Schering)\", \"Clinical\", \"nan\", \"nan\", \"World Health Organization Chinese Clinical Trial Registry\", \"PegIntron - FDA-approved since 2001, approved to treat Hepatitis C; Sylatron - FDA-approved since 2001, approved for the adjuvant treatment of melanoma; Intron A - FDA-approved since 1986, approved to treat Hepatitis C and certain cancers\", \"nan\", \"nan\"], [5, \"61\", \"Novaferon, Nova, interferon, licensed in China for Hepatitis B\", \"nan\", \"The First Affiliated Hospital of Zhejiang University Medical School\", \"Clinical\", \"nan\", \"nan\", \"nan\", \"N/A\", \"nan\", \"nan\"], [0, \"62\", \"Recombinant ACE2 (angiotensin-converting enzyme 2)\", \"nan\", \"The First Affiliated Hospital of Guangzhou Medical University\", \"Clinical\", \"nan\", \"Primary trial ends April 1, 2020\", \"BioCentury ClinicalTrials.gov\", \"Unknown\", \"nan\", \"nan\"], [1, \"63\", \"Cerocal (ifenprodil), NP-120, an NDMA receptor glutamate receptor antagonist targeting\", \"nan\", \"Algernon Pharmaceuticals\", \"Pre-clinical\", \"nan\", \"nan\", \"Clinical Trials Arena Algernon Pharmaceuticals\", \"N/A\", \"Idiopathic Pulmonary Fibrosis\", \"nan\"], [3, \"64\", \"APN01; recombinant soluble human Angiotensin Converting Enzyme 2\", \"nan\", \"University of British Columbia/ Apeiron Biologics\", \"Clinical\", \"nan\", \"In Phase 1 pilot in China\", \"Clinical Trials Arena Apeiron Biologics ClinicalTrials.gov\", \"N/A\", \"Acute lung injury, Acute respiratory distress syndrome, Pulmonary arterial hypertension\", \"nan\"], [4, \"65\", \"Brilacidin, a defensin mimetic\", \"nan\", \"Innovation Pharmaceuticals\", \"Pre-clinical\", \"nan\", \"nan\", \"Clinical Trials Arena Innovation Pharmaceuticals\", \"N/A\", \"Oral Mucositis; Ulcerative Proctitis/Ulcerative Proctosigmoiditis; Acute Bacterial Skin and Skin Structure Infection\", \"nan\"], [5, \"66\", \"BXT-25; glycoprotein\", \"nan\", \"Bioxytran\", \"Pre-clinical\", \"nan\", \"nan\", \"Clinical Trials Arena\", \"N/A\", \"nan\", \"nan\"], [6, \"67\", \"Peptides targeting the NP protein\", \"nan\", \"CEL-SCI/University of Georgia Center for Vaccines and Immunology\", \"Pre-clinical\", \"nan\", \"nan\", \"Clinical Trials Arena CEL-SCI Corporation press release\", \"Unknown\", \"nan\", \"nan\"], [7, \"68\", \"BIO-11006, inhaled peptide\", \"nan\", \"Biomarck Pharmaceuticals\", \"Clinical\", \"nan\", \"nan\", \"Biomarck Pharmaceuticals\", \"N/A\", \"Acute Respiratory Distress Syndrome; Non-Small Cell Lung Cancer; Chronic Obstructive Pulmonary Disease (COPD)\", \"nan\"], [8, \"69\", \"Gilenya (fingolimod), sphingosine 1-phosphate receptor modulator\", \"nan\", \"The First Affiliated Hospital of Fujian Medical University/Novartis\", \"Clinical\", \"nan\", \"Primary trial ends July 2020\", \"ClinicalTrials.gov\", \"FDA-approved since 2010, approved to treat multiple sclerosis\", \"nan\", \"nan\"], [9, \"70\", \"WP1122, glucose decoy prodrug (and related drug candidates)\", \"nan\", \"Moleculin Biotech/University of Texas Medical Branch\", \"Pre-clinical\", \"nan\", \"nan\", \"FierceBiotech Moleculin\", \"N/A\", \"nan\", \"nan\"], [10, \"71\", \"Rebif (interferon beta-1a)\", \"nan\", \"Institut National de la Sante et de la Recherche Medicale (Merck KGaA)\", \"Clinical\", \"nan\", \"nan\", \"Merck KGaA press release\", \"FDA-approved since 2002, approved to treat multiple sclerosis\", \"nan\", \"nan\"], [0, \"72\", \"nafamostat, approved in Japan to treat pancreatitis and other diseases\", \"nan\", \"University of Tokyo/ National Center for Global Health and Medicine\", \"Pre-clinical\", \"nan\", \"Trial starts April 2020\", \"Bloomberg News\", \"N/A\", \"nan\", \"nan\"], [1, \"73\", \"A number of synthesized nanoviricide drug candidates\", \"nan\", \"NanoViricides\", \"Pre-clinical\", \"nan\", \"nan\", \"Clinical Trials Arena NanoViricides Inc.\", \"N/A\", \"nan\", \"nan\"], [2, \"74\", \"losartan\", \"nan\", \"University of Minnesota\", \"Clinical\", \"nan\", \"nan\", \"ClinicalTrials.gov KARE TV\", \"FDA-approved since 1995, approved to treat hypertension and diabetic nephropathy\", \"nan\", \"nan\"], [3, \"75\", \"Activase (alteplase), tissue plasminogen activator (tPA)\", \"nan\", \"Beth Israel Deaconess, the University of Colorado Anschultz Medical Campus, and Denver Health (Genentech)\", \"Compassionate Use\", \"nan\", \"nan\", \"MIT News\", \"FDA-approved since 1987, approved to treat stroke, myocardial infarction, and pulmonary embolism\", \"nan\", \"nan\"], [5, \"1\", \"Washed microbiota transplantation\", \"nan\", \"The Second Hospital of Nanjing Medical University\", \"Clinical\", \"nan\", \"Primary trial ends April 2, 2020\", \"nan\", \"Unknown\", \"nan\", \"nan\"]]};\n",
       "        dt_args = eval_functions(dt_args);\n",
       "        table = $('#220c6231-056c-4f32-bbdd-dac776807ef9').DataTable(dt_args);\n",
       "    });\n",
       "})\n",
       "</script>\n",
       "</div>\n"
      ],
      "text/plain": [
       "   Number                        Type of Product - Treatment  \\\n",
       "1       1        TAK-888, antibodies from recovered COVID-19   \n",
       "3       2  Antibodies from mice, REGN3048-3051, against t...   \n",
       "4       3        Antibodies from recovered COVID-19 patients   \n",
       "5       4        Antibodies from recovered COVID-19 patients   \n",
       "6       5        Antibodies from recovered COVID-19 patients   \n",
       "..    ...                                                ...   \n",
       "0      72  nafamostat, approved in Japan to treat pancrea...   \n",
       "1      73  A number of synthesized nanoviricide drug cand...   \n",
       "2      74                                           losartan   \n",
       "3      75  Activase (alteplase), tissue plasminogen activ...   \n",
       "5       1                  Washed microbiota transplantation   \n",
       "\n",
       "   FDA-Approved Indications  \\\n",
       "1                       N/A   \n",
       "3                       N/A   \n",
       "4                       N/A   \n",
       "5                       N/A   \n",
       "6                       N/A   \n",
       "..                      ...   \n",
       "0                       NaN   \n",
       "1                       NaN   \n",
       "2                       NaN   \n",
       "3                       NaN   \n",
       "5                       NaN   \n",
       "\n",
       "                                 Developer/Researcher  \\\n",
       "1                                              Takeda   \n",
       "3                                           Regeneron   \n",
       "4                                           Celltrion   \n",
       "5                                              Kamada   \n",
       "6                   Vir Biotech/WuXi Biologics/Biogen   \n",
       "..                                                ...   \n",
       "0   University of Tokyo/ National Center for Globa...   \n",
       "1                                       NanoViricides   \n",
       "2                             University of Minnesota   \n",
       "3   Beth Israel Deaconess, the University of Color...   \n",
       "5   The Second Hospital of Nanjing Medical University   \n",
       "\n",
       "   Current Stage of Development  \\\n",
       "1                  Pre-clinical   \n",
       "3                  Pre-clinical   \n",
       "4                  Pre-clinical   \n",
       "5                  Pre-clinical   \n",
       "6                  Pre-clinical   \n",
       "..                          ...   \n",
       "0                  Pre-clinical   \n",
       "1                  Pre-clinical   \n",
       "2                      Clinical   \n",
       "3             Compassionate Use   \n",
       "5                      Clinical   \n",
       "\n",
       "                                      Funding Sources  \\\n",
       "1                                                 NaN   \n",
       "3   Biomedical Advanced Research and Development A...   \n",
       "4                                                 NaN   \n",
       "5                                                 NaN   \n",
       "6                                                 NaN   \n",
       "..                                                ...   \n",
       "0                                                 NaN   \n",
       "1                                                 NaN   \n",
       "2                                                 NaN   \n",
       "3                                                 NaN   \n",
       "5                                                 NaN   \n",
       "\n",
       "                        Anticipated Next Steps Timing  \\\n",
       "1   To patients between September 2020 and Septemb...   \n",
       "3                             Start Phase 1 June 2020   \n",
       "4                        Start Phase 1 September 2020   \n",
       "5                                                 NaN   \n",
       "6                           Start Phase 1 ~ July 2020   \n",
       "..                                                ...   \n",
       "0                             Trial starts April 2020   \n",
       "1                                                 NaN   \n",
       "2                                                 NaN   \n",
       "3                                                 NaN   \n",
       "5                    Primary trial ends April 2, 2020   \n",
       "\n",
       "                                              Sources  \\\n",
       "1                           PhRMA Wall Street Journal   \n",
       "3   Stat News MarketWatch Reuters Bloomberg News F...   \n",
       "4                                        Korea Herald   \n",
       "5                                     BioSpace AbbVie   \n",
       "6                               Stat News Vir Biotech   \n",
       "..                                                ...   \n",
       "0                                      Bloomberg News   \n",
       "1            Clinical Trials Arena NanoViricides Inc.   \n",
       "2                          ClinicalTrials.gov KARE TV   \n",
       "3                                            MIT News   \n",
       "5                                                 NaN   \n",
       "\n",
       "                FDA-Approved Indications (Treatments)  \\\n",
       "1                                                 NaN   \n",
       "3                                                 NaN   \n",
       "4                                                 NaN   \n",
       "5                                                 NaN   \n",
       "6                                                 NaN   \n",
       "..                                                ...   \n",
       "0                                                 N/A   \n",
       "1                                                 N/A   \n",
       "2   FDA-approved since 1995, approved to treat hyp...   \n",
       "3   FDA-approved since 1987, approved to treat str...   \n",
       "5                                             Unknown   \n",
       "\n",
       "   Clinical Trials Ongoing for Other Diseases Developer/ Researcher  \n",
       "1                                         NaN                   NaN  \n",
       "3                                         NaN                   NaN  \n",
       "4                                         NaN                   NaN  \n",
       "5                                         NaN                   NaN  \n",
       "6                                         NaN                   NaN  \n",
       "..                                        ...                   ...  \n",
       "0                                         NaN                   NaN  \n",
       "1                                         NaN                   NaN  \n",
       "2                                         NaN                   NaN  \n",
       "3                                         NaN                   NaN  \n",
       "5                                         NaN                   NaN  \n",
       "\n",
       "[76 rows x 11 columns]"
      ]
     },
     "execution_count": 17,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_all"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Citation\n",
    "\n",
    "Lucas, A. COVID-19 Vaccine Development Tracker. 27 Mar. 2020, covid-vaccine-tracker.com. DOI:10.5281/zenodo.3731761"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.6"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 4
}
